Importance of Medicinal Compounds from Traditional Plants for the Treatment of Endometriosis

Endometriosis is a challenging gynecological disorder that causes pelvic pain and infertility attributed to the prevalence of ectopic endometrial tissue outside the uterine tract. Based on the patient’s histology findings, it is typically identified by pathological lesions, endometritis, pyometra, and glandular cystic hyperplasia. Traditional medicines are thought to be the most reliable sources for the discovery of novel pharmaceuticals, notwithstanding recent developments in computational and chemical techniques. Endometriosis and other gynecological illnesses have been tested against a variety of therapeutic herbs and chemicals derived from plants. In healthcare areas with few resources, traditional medicine is still seen as the main treatment option, regardless of recent scientific progress and globalization. Plant-derived compounds were once thought to be a key source of modern medications and play a crucial biological role against some pathogenic organisms. Ever since the dawn of humanity, an increasing number of plants have been utilized as remedies. In communities all across the world, traditional medicine has been an essential resource for health for centuries, and it is still a cornerstone for some people who have unequal access to mainstream treatment, according to research conducted by the World Health Organization (WHO). This book chapter presents the activity profile of medicinal plants and their active components while highlighting the development of multitargeted endometriosis medicinal compounds. Access this chapter Tax calculation will be finalised at checkout Purchases are for personal use only Similar content being viewed by others

Acién P, Velasco I (2013) Endometriosis: a disease that remains enigmatic. ISRN Obstet Gynecol 2013:1–12. https://doi.org/10.1155/2013/242149 Agarwal SK et al (2019) Clinical diagnosis of endometriosis: a call to action. Am J Obstet Gynecol 220(4):354.e1–354.e12. https://doi.org/10.1016/j.ajog.2018.12.039 Alessandro P, Luigi N, Felice S, Maria PA, Benedetto MG, Stefano A (2017) Research development of a new GnRH antagonist (Elagolix) for the treatment of endometriosis: a review of the literature. Arch Gynecol Obstet 295(4):827–832. https://doi.org/10.1007/s00404-017-4328-6. Springer Verlag Angioni S, D’alterio MN, Coiana A, Anni F, Gessa S, Deiana D (2020) Genetic characterization of endometriosis patients: review of the literature and a prospective cohort study on a mediterranean population. Int J Mol Sci 21(5):1765. https://doi.org/10.3390/ijms21051765 Asante A, Taylor RN (2011) Endometriosis: the role of neuroangiogenesis. Annu Rev Physiol 73:163–182. https://doi.org/10.1146/annurev-physiol-012110-142158 Attar E, Bulun SE (2006) Aromatase inhibitors: the next generation of therapeutics for endometriosis? Fertil Steril 85(5):1307–1318. https://doi.org/10.1016/j.fertnstert.2005.09.064 Avid D, Live LO, Ritts LAP (2001) Drug therapy treatment of endometriosis. N Engl J Med. www.nejm.org Bahat PY, Ayhan I, Ozdemir EU, Inceboz Ü, Oral E (2022) Dietary supplements for treatment of endometriosis: a review. Acta Biomed 93(1):e2022159. https://doi.org/10.23750/abm.v93i1.11237. Mattioli 1885 Barbieri RL (1990) Etiology and epidemiology of endometriosis. Am J Obstet Gynecol 162(2):565–567. https://doi.org/10.1016/0002-9378(90)90430-F Benagiano G, Brosens I (1991) The history of endometriosis: identifying the disease. https://academic.oup.com/humrep/article-abstract/6/7/963/584156 Benagiano G, Brosens I (2006) History of adenomyosis. Best Pract Res Clin Obstet Gynaecol 20(4):449–463. https://doi.org/10.1016/j.bpobgyn.2006.01.007 Benagiano G, Brosens I (2011) Who identified endometriosis? Fertil Steril 95(1):13–16. https://doi.org/10.1016/j.fertnstert.2010.06.027 Benagiano G, Brosens I, Lippi D (2014) The history of endometriosis. Gynecol Obstet Invest 78(1):1–9. https://doi.org/10.1159/000358919. S. Karger AG Bennett JA, Fleming GF, Kurnit KC, Mills KA, van Weelden WJ (2022) Tumor board presentation of a woman with metastatic, hormone receptor-positive, mismatch repair-deficient endometrial cancer. CA Cancer J Clin 72(2):102–111. https://doi.org/10.3322/caac.21715 Berkkanoglu M, Arici A (2003) Immunology and endometriosis. Am J Reprod Immunol 50. https://doi.org/10.1034/j.1600-0897.2003.00042.x Brown J, Farquhar C (2015) An overview of treatments for endometriosis. http://jama.jamanetwork.com/ Spaczynski RZ, Duleba AJ (2003) Diagnosis of endometriosis. Semin Reprod Med 21(2):193–208. https://doi.org/10.1055/s-2003-41326 Chapron C, Marcellin L, Borghese B, Santulli P (2019) Rethinking mechanisms, diagnosis and management of endometriosis. Nat Rev Endocrinol 15(11):666–682. https://doi.org/10.1038/s41574-019-0245-z. Nature Publishing Group Dababou S et al (2021) Linzagolix: a new GnRH-antagonist under investigation for the treatment of endometriosis and uterine myomas. Expert Opin Investig Drugs 30(9):903–911. https://doi.org/10.1080/13543784.2021.1957830 Dardes RC, Schafer JMG, Pearce ST, Osipo C, Chen B, Jordan VC (2002) Regulation of estrogen target genes and growth by selective estrogen-receptor modulators in endometrial cancer cells. Gynecol Oncol 85(3):498–506. https://doi.org/10.1006/gyno.2002.6659 Dmowski WP, Radwanska E (1984) Current concepts on pathology, histogenesis and etiology of endometriosis. Acta Obstet Gynecol Scand 63(123):29–33. https://doi.org/10.3109/00016348409156978 Donnez J, Dolmans MM (2021) Endometriosis and medical therapy: from progestogens to progesterone resistance to GNRH antagonists: a review. J Clin Med 10(5):1–21. https://doi.org/10.3390/jcm10051085 Farnell YZ, Ing NH (2003) The effects of estradiol and selective estrogen receptor modulators on gene expression and messenger RNA stability in immortalized sheep endometrial stromal cells and human endometrial adenocarcinoma cells. J Steroid Biochem Mol Biol 84(4):453–461. https://doi.org/10.1016/S0960-0760(03)00066-9 Ferrero S, Ragni N, Remorgida V (2006) Antiangiogenic therapies in endometriosis. Br J Pharmacol 149(2):133–135. https://doi.org/10.1038/sj.bjp.0706860 Fu J et al (2017) Progesterone receptor modulators for endometriosis. Cochrane Database Syst Rev 2017(7):CD009881. https://doi.org/10.1002/14651858.cd009881.pub2 Gallagher CS et al (2019) Genome-wide association and epidemiological analyses reveal common genetic origins between uterine leiomyomata and endometriosis. Nat Commun 10(1):4857. https://doi.org/10.1038/s41467-019-12536-4 Ghonemy GE, El Sharkawy NB (2017) Impact of changing lifestyle on endometriosis related pain. IOSR J Nurs Health Sci 06(02):120–129. https://doi.org/10.9790/1959-060205120129 Guo SW (2009) Recurrence of endometriosis and its control. Hum Reprod Update 15(4):441–461. https://doi.org/10.1093/humupd/dmp007 Halpern G, Schor E, Kopelman A (2015) Nutritional aspects related to endometriosis. Rev Assoc Med Bras 61(6):519–523. https://doi.org/10.1590/1806-9282.61.06.519 Hudson N (2022) The missed disease? Endometriosis as an example of ‘undone science’. Reprod Biomed Soc Online 14:20–27. https://doi.org/10.1016/j.rbms.2021.07.003 Hull ML et al (2003) Antiangiogenic agents are effective inhibitors of endometriosis. J Clin Endocrinol Metab 88(6):2889–2899. https://doi.org/10.1210/jc.2002-021912 Ilhan M, Gürağaç Dereli FT, Akkol EK (2018) Novel drug targets with traditional herbal medicines for overcoming endometriosis. Curr Drug Deliv 16(5):386–399. https://doi.org/10.2174/1567201816666181227112421 Johnson NP, Hummelshoj L (2013) Consensus on current management of endometriosis. Hum Reprod 28(6):1552–1568. https://doi.org/10.1093/humrep/det050 Kiesel L, Sourouni M (2019) Diagnosis of endometriosis in the 21st century. Climacteric 22(3):296–302. https://doi.org/10.1080/13697137.2019.1578743. Taylor and Francis Ltd Kim KH et al (2013) Hexane extract of aged black garlic reduces cell proliferation and attenuates the expression of ICAM-1 and VCAM-1 in TNF-α-activated human endometrial stromal cells. Int J Mol Med 32(1):67–78. https://doi.org/10.3892/ijmm.2013.1362 Kim JH, Woo JH, Kim HM, Oh MS, Jang DS, Choi JH (2017) Anti-endometriotic effects of pueraria flower extract in human endometriotic cells and mice. Nutrients 9(3):212. https://doi.org/10.3390/nu9030212 Kinkel K, Frei KA, Balleyguier C, Chapron C (2006) Diagnosis of endometriosis with imaging: a review. Eur Radiol 16(2):285–298. https://doi.org/10.1007/s00330-005-2882-y Knapp VJ (1999) How old is endometriosis? Late 17th-and 18th-century European descriptions of the disease. Fertil Steril 72(1):10–14 Kolahdouz Mohammadi R, Arablou T (2017) Resveratrol and endometriosis: in vitro and animal studies and underlying mechanisms (Review). Biomed Pharmacother 91:220–228. https://doi.org/10.1016/j.biopha.2017.04.078. Elsevier Masson SAS Küpker W, Felberbaum RE, Krapp M, Schill T, Malik E, Diedrich K (2002) Use of GnRH antagonists in the treatment of endometriosis. Reprod Biomed Online 5(1):12–16. https://doi.org/10.1016/S1472-6483(10)61590-8 Maclean JA, Hayashi K (2022) Progesterone actions and resistance in gynecological disorders. Cell 11(4):647. https://doi.org/10.3390/cells11040647 Mahmood TA, Templeton A (1991) Prevalence and genesis of endometriosis. https://academic.oup.com/humrep/article-abstract/6/4/544/639892 Martin DC (2012) A history of endometriosis. J Minim Invasive Gynecol 19(2):269–270. https://doi.org/10.1016/j.jmig.2011.12.008 Mehedintu C, Plotogea MN, Ionescu S, Antonovici M (2014) Endometriosis still a challenge. J Med Life 7(3):349–357. PMID: 25408753 Meresman GF, Götte M, Laschke MW (2021) Plants as source of new therapies for endometriosis: a review of preclinical and clinical studies. Hum Reprod Update 27(2):367–392. https://doi.org/10.1093/humupd/dmaa039. Oxford University Press Mihalyi A, Simsa P, Mutinda KC, Meuleman C, Mwenda JM, D’Hooghe TM (2006) Emerging drugs in endometriosis. Expert Opin Emerg Drugs 11(3):503–524. https://doi.org/10.1517/14728214.11.3.503 Nezhat C, Nezhat F, Nezhat C (2012) Endometriosis: ancient disease, ancient treatments. Fertil Steril 98(6 Suppl):S1. https://doi.org/10.1016/j.fertnstert.2012.08.001. Elsevier Inc Osteen KG, Bruner-Tran KL, Eisenberg E (2005) Endometrial biology and the etiology of endometriosis. Fertil Steril 84(1):33–34. https://doi.org/10.1016/j.fertnstert.2005.01.124 Patel D, Shukla S, Gupta S (2007) Apigenin and cancer chemoprevention: progress, potential and promise (Review). Int J Oncol 30:233–245. https://doi.org/10.3892/ijo.30.1.233 Pavone ME, Bulun SE (2012) Aromatase inhibitors for the treatment of endometriosis. Fertil Steril 98(6):1370–1379. https://doi.org/10.1016/j.fertnstert.2012.08.053 Ranney B (1975) The prevention, inhibition, palliation, and treatment of endometriosis. Am J Obstet Gynecol 123(8):778–785. https://doi.org/10.1016/0002-9378(75)90849-2 Rodgers AK, Falcone T (2008) Treatment strategies for endometriosis. Expert Opin Pharmacother 9(2):243–255. https://doi.org/10.1517/14656566.9.2.243 Saltan G et al (2016) Viburnum opulus L.: a remedy for the treatment of endometriosis demonstrated by rat model of surgically-induced endometriosis. J Ethnopharmacol 193:450–455. https://doi.org/10.1016/j.jep.2016.09.029 Seydel AS, Sickel JZ, Warner ED, Sax HC, York N (1996) Extrapelvic endometriosis: diagnosis and treatment. Am J Surg 171(2):239 Takayama K, Zeitoun K, Gunby RT, Sasano H, Carr BR, Bulun SE (1998) Treatment of severe postmenopausal endometriosis with an aromatase inhibitor. Fertil Steril 69(4):709–713 Terzic M et al (2021) Molecular basis of endometriosis and endometrial cancer: current knowledge and future perspectives. Int J Mol Sci 22(17):9274. https://doi.org/10.3390/ijms22179274 Vallée A, Lecarpentier Y (2020) Curcumin and endometriosis. Int J Mol Sci 21(7):2440. https://doi.org/10.3390/ijms21072440. MDPI AG Vercellini P, Viganò P, Somigliana E, Fedele L (2014) Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol 10(5):261–275. https://doi.org/10.1038/nrendo.2013.255 Author information Authors and Affiliations Editor information Editors and Affiliations Rights and permissions Copyright information © 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. About this chapter Cite this chapter Rishikesan, S., Devi, P.B. (2023). Importance of Medicinal Compounds from Traditional Plants for the Treatment of Endometriosis. In: Singh, R., Kumar, N. (eds) Genetic Manipulation of Secondary Metabolites in Medicinal Plant. Interdisciplinary Biotechnological Advances. Springer, Singapore. https://doi.org/10.1007/978-981-99-4939-7_11 Download citation DOI: https://doi.org/10.1007/978-981-99-4939-7_11 Published: Publisher Name: Springer, Singapore Print ISBN: 978-981-99-4938-0 Online ISBN: 978-981-99-4939-7 eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)